(Q46819434)

25 December 2017

title

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study (English)

1 reference

25 December 2017

relapsing-remitting multiple sclerosis

main subject

multiple sclerosis

0 references

0 references

author

Alan J. Thompson

9

1 reference

25 December 2017

author name string

M Tiberio

1

1 reference

25 December 2017

D T Chard

2

1 reference

25 December 2017

D R Altmann

3

1 reference

25 December 2017

G Davies

4

1 reference

25 December 2017

C M Griffin

5

1 reference

25 December 2017

M A McLean

6

1 reference

25 December 2017

W Rashid

7

1 reference

25 December 2017

J Sastre-Garriga

8

1 reference

25 December 2017

D H Miller

10

1 reference

25 December 2017

publication date

24 November 2005

1 reference

25 December 2017

published in

Journal of Neurology

1 reference

25 December 2017

volume

253

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

224-230

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-005-0964-z

exact match

0 references

cites work

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0964-Z

Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0964-Z

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0964-Z

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0964-Z

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

21 January 2018

1 reference

12 December 2020

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

12 December 2020

Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

1 reference

12 December 2020

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability

1 reference

12 December 2020

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

1 reference

12 December 2020

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

Quantitative analysis of short echo time1H-MRSI of cerebral gray and white matter

1 reference

12 December 2020

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model

1 reference

12 December 2020

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

12 December 2020

Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

12 December 2020

Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease

1 reference

12 December 2020

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study

1 reference

12 December 2020

Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.

1 reference

12 December 2020

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

12 December 2020

Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid

1 reference

12 December 2020

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

12 December 2020

Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study

1 reference

12 December 2020

Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve

1 reference

12 December 2020

Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study

1 reference

12 December 2020

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

12 December 2020

10.1007/S00415-005-0964-Z

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16307201

1 reference

25 December 2017